<DOC>
	<DOCNO>NCT01164904</DOCNO>
	<brief_summary>To assess safety tolerability single subcutaneous ( SC ) intravenous ( IV ) dose AMG 181 healthy subject single SC dose subject mild moderate ulcerative colitis ( UC )</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics AMG 181 Healthy Subjects Subjects With Mild Moderate Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Healthy Volunteers Healthy male female subject nonreproductive potential 18 45 yearof age Body Mass Index ( BMI ) 18 34 kg/m2 Normal physical neurological examination , clinical laboratory value ECG Additional inclusion criterion apply Subjects Mild Moderate Ulcerative Colitis Male female subject 18 55 yearof age Body Mass Index ( BMI ) 18 34 kg/m2 Diagnosis Ulcerative Colitis least 2 month Active , mild moderate disease define Ulcerative Colitis Disease Activity Index ( UCDAI , aka Mayo score ) score 4 9 ( inclusive ) , minimum sigmoidoscopy score 1 Additional inclusion criterion apply Exclusion criterion : Healthy Volunteers History evidence clinically significant disorder ( include psychiatric ) , condition disease would pose risk subject safety interfere study evaluation , procedure completion History malignancy type , situ cervical cancer surgically excise nonmelanomatous skin cancer within past 5 year Recent ongoing infection ( ) Underlying condition ( ) predispose subject infection Additional exclusion criterion apply Exclusion criterion : Subjects Mild Moderate Ulcerative Colitis Disease limit rectum , i.e . within 20 cm anal verge Any prior gastrointestinal surgery Evidence severe disease ( evidence Hb concentration &lt; 11g/dL ; toxic megacolon , UCDAI scoreâ‰¥10 ) Immunosuppressive therapy either azathioprine , methotrexate , mercaptopurine , within past 3 month Prior exposure biologic agent cyclosporine A Use antibiotic within past 2 week screen screen period Use topical ( e.g . suppository enema ) mesalamine steroid within two week prior day 1 Additional exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Amgen</keyword>
</DOC>